Evidence map›Paper›PMID 42472184›Full record

ArticleStem cells international2026

Large-Scale Production of Secretome From Human Dental Pulp Stem Cells for Articular Cartilage Regeneration.

Lucía Bravo-Baranda, Lara Milián, María Sancho-Tello, Mauro Llop-Miguel, Irene Monleón-Guinot, Cristina Martínez-Ramos, José Manuel Morales-Tatay, María Fe Mínguez-Rey, Manuel Mata

Abstract read
In one paragraph

Article in Stem cells international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lucía Bravo-BarandaDepartment of Pathology, University of Valencia, Valencia, Spain, uv.es.ORCID https://orcid.org/0009-0004-4405-3371
Lara MiliánDepartment of Pathology, University of Valencia, Valencia, Spain, uv.es.ORCID https://orcid.org/0000-0001-6889-1901
María Sancho-TelloDepartment of Pathology, University of Valencia, Valencia, Spain, uv.es.ORCID https://orcid.org/0000-0002-7080-2979
Mauro Llop-MiguelDepartment of Pathology, University of Valencia, Valencia, Spain, uv.es.ORCID https://orcid.org/0009-0002-2690-0747
Irene Monleón-GuinotDepartment of Pathology, University of Valencia, Valencia, Spain, uv.es.ORCID https://orcid.org/0000-0002-1153-0395
Cristina Martínez-RamosDepartment of Pathology, University of Valencia, Valencia, Spain, uv.es.ORCID https://orcid.org/0000-0002-6540-4714
José Manuel Morales-TatayDepartment of Pathology, University of Valencia, Valencia, Spain, uv.es.ORCID https://orcid.org/0000-0002-4404-6735
María Fe Mínguez-ReyDepartment of Surgery, University of Valencia, Valencia, Spain, uv.es.ORCID https://orcid.org/0000-0002-2413-9731
Manuel MataDepartment of Pathology, University of Valencia, Valencia, Spain, uv.es.ORCID https://orcid.org/0000-0002-1506-7983

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Articular cartilage degeneration can lead to a progressive loss of joint function and, eventually, total joint failure. The use of mesenchymal stem cells (MSCs) for cartilage regeneration has proven effective; however, the difficulty of their clinical application has prompted research into other strategies, such as using MSC secretome instead of cells themselves. Our aim was to generate a culture system to obtain large amounts of MSC secretome with a controlled and known composition and the potential to induce articular cartilage regeneration. Methods: Human dental pulp stem cells (hDPSCs) embedded in alginate/agarose beads were cultured in a bioreactor with constant agitation and periodic culture medium exchange. The secretome was collected and characterized according to known chondral markers (TGF-β1, SERPINE1, miR-140, miR-675, miR-23a, miR-204, miR-211, and miR-337-5p). Metabolomic and proteomic analyses were carried out for detailed characterization of the collected secretome. The chondrogenic potential of the collected secretome was tested in an in vitro model developed using human primary chondrocytes cultured in 3D on alginate-agarose scaffolds. Results: Our system allowed us to obtain 1200 mL of secretome from intensive cultures of hDPSCs. The cells cultured on the platform remained viable and in an active anabolic state, secreting large amounts of prochondrogenic mediators. Variability between batches of secretome was low, and the collected secretome induced primary chondrocyte differentiation in vitro. Conclusions: Genomic, metabolomic, and proteomic data indicate that hDPSCs on the platform proliferate and acquire a chondrocyte-like phenotype. These cells secrete mediators that define a microenvironment favorable for chondral regeneration. This is further supported by evidence found in the in vitro differentiation model. Our platform allows the production of large volumes of secretome with controlled composition and chondrogenic induction potential. This is a necessary preclinical study for the subsequent analysis of the secretome obtained using in vivo experimental models.

Indexed as

cartilage regenerationhuman dental pulp stem cells (hDPSCs)mesenchymal stem cells (MSCs)osteoarthritissecretome

Identifiers

PMID42472184
PMCPMC13379900

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.